| Previous Close | 43.43 |
| Open | 43.43 |
| Bid | 43.14 |
| Ask | 44.66 |
| Day Low-High | 43.35-43.83 |
| 52wk Low-High | 29.94-45.35 |
| Avg Volume | 33,666.00 |
| NAV | 42.24 |
| Premium | +1.59 |
| Expense Ratio | 0.60 % |
| Dividend (Yield) | $0.00 (0.00%) |
| Ex-Dividend Date | |
Management
Company | FIRST TRUST ADVISORS |
BENCHMARK for FBT
NYSE ARCA BIOTECHNOLOGY INDEX
This Index is an equal dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. Eg, recombinant DNA technology, molecular biology, genetic engineering, monoclonal antibody-based technology, lipid/liposome technology, and genomics.
FUND SUMMARY for FBT
FIRST TRUST AMEX BIOTECHNOLOGY F
The First Trust AMEX(R) Biotechnology Index Fund is and exchange-traded index fund. The investment objective of the fund is to replicate as closely as possible, before fees and expenses, the price and yield of the AMEX(R) Biotechnology Index(SM) . The Amex Biotechnology IndexSM is an equal dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. Such processes include, but are not limited to, recombinant DNA technology, molecular biology, genetic engineering, monoclonal antibody-based technology, lipid/liposome technology, and genomics. The index is rebalanced quarterly based on closing prices on the third Friday in January, April, July & October to ensure that each component stock continues to represent approximately equal weight in the index.
Sponsored Links 
